Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-020624
Filing Date
2020-07-29
Accepted
2020-07-29 16:18:29
Documents
1
Period of Report
2020-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3923
  Complete submission text file 0000899243-20-020624.txt   5270
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
Macdonald Guy (Reporting) CIK: 0001296998 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35837 | Film No.: 201057463

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Issuer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations